Amos Hedt

Chief Business Strategy Officer

‍Viewpoint Molecular Targeting, Inc.

Chief Business Strategy Officer

‍Viewpoint Molecular Targeting, Inc.

#theranostics #drugdevelopment #targetedtherapy #radiopharmaceuticals

#NorthAmerica

Mr. Hedt is an experienced research professional with over 20 years in the biotechnology and pharmaceutical industries and a comprehensive understanding of all stages of drug research, development, an

Joseph Osborne

Professor of Radiology

‍Weill Cornell Medicine

Professor of Radiology

‍Weill Cornell Medicine

#radiology #theranostics #radhealthequity #innovationleadership

#NorthAmerica

My vision for our Molecular Imaging and Therapeutics Service is to translate the best science into practice.